文献速递新发突发、热带与寄生虫病

沙眼衣原体在不同解剖部位的存活性:系统综述与荟萃分析

Viability of Chlamydia trachomatis in Different Anatomical Sites-a Systematic Review and Meta-analysis.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该系统综述与荟萃分析检索了2000年1月至2023年5月的文献,纳入16项测量核酸扩增检测阳性样本中沙眼衣原体存活性的研究,按解剖部位汇总不可存活沙眼衣原体的比例:直肠拭子33%、宫颈拭子17%、阴道拭子15%、尿液/尿道拭子11%。所有纳入研究均发现部分核酸扩增检测到的沙眼衣原体不可存活。

要点

  • 所有纳入研究均发现核酸扩增检测到的沙眼衣原体中有部分不可存活。
  • 直肠拭子中不可存活沙眼衣原体汇总比例为33%(95%CI 19%-47%)。
  • 尿液/尿道拭子中不可存活沙眼衣原体汇总比例为11%(95%CI 9%-17%)。

核心结论

  • 所有纳入研究均发现核酸扩增检测到的沙眼衣原体中有一定比例不可存活,这对筛查项目及评估新性传播感染检测和抗菌方案的研究具有深远影响。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE、Scopus和Dimensions以及会议摘要中2000年1月至2023年5月间收录的文献,纳入任何测量核酸扩增检测阳性样本中沙眼衣原体存活性的研究,共筛选31342条记录,最终纳入16项研究进行分析。

主要发现

  • 按解剖部位汇总的不可存活沙眼衣原体比例:直肠拭子33%(95%CI 19%-47%,8项研究),宫颈拭子17%(95%CI 7%-27%,6项研究),阴道拭子15%(95%CI 6%-25%,6项研究),尿液/尿道拭子11%(95%CI 9%-17%,2项研究)。

关键数值与推荐

  • 存活性检测方法包括增强细胞培养、直接荧光抗体(DFA)、通过微滴式数字聚合酶链反应(PCR,ddPCR)检测信使RNA(mRNA)、存活性PCR(V-PCR)以及测量RNA与DNA比值的实时PCR(RDR)(如InSignia®)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Modern assays for the detection of Chlamydia trachomatis (CT) rely on nucleic acid amplification testing (NAAT) of DNA or ribosomal RNA. However, it is also known that both viable ("living") and non-viable ("dead") CT can be detected by NAAT. Multiple laboratory techniques to measure CT viability have emerged. METHODS: We searched PubMed, EMBASE, Scopus, and Dimensions as well as conference abstracts for entries between January 2000 and May 2023. We included any studies that measured CT viability among NAAT-positive samples. Viability assays include enhanced cell culture, direct fluorescent antibody (DFA), messenger RNA (mRNA) detection via digital droplet polymerase chain reaction (PCR, ddPCR), viability PCR (V-PCR), and real-time PCR measuring RNA-to-DNA ratio (RDR) (eg, InSignia®). A meta-analysis was performed on the proportions of non-viable CT by anatomical site. RESULTS: We screened 31 342 records and included 16 studies in the analysis. The pooled proportions of non-viable CT by site were: 33% (95% confidence interval [CI]: 19%-47%) in rectal swabs (8 studies), 17% (95% CI: 7%-27%) in cervical swabs (6 studies), 15% (95% CI: 6%-25%) in vaginal swabs (6 studies), and 11% (95% CI: 9%-17%) in urine/urethral swabs (2 studies). CONCLUSIONS: All included studies found that a proportion of NAAT-detected CT is non-viable. The findings have far-reaching implications for screening programs and studies evaluating new STI tests and antimicrobial regimens.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wong A, Lima N, Applegate TL, et al. Viability of Chlamydia trachomatis in Different Anatomical Sites-a Systematic Review and Meta-analysis. Clin Infect Dis. 2026. PMID: 39102890. doi:10.1093/cid/ciae401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。